Mary Fisher - Aug 17, 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
Director
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Stock symbol
DRMA
Transactions as of
Aug 17, 2021
Transactions value $
$0
Form type
4
Date filed
8/17/2021, 12:42 PM
Previous filing
Aug 12, 2021
Next filing
Jan 5, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to Buy) Award $0 +10K $0.00 10K Aug 17, 2021 Common Stock 10K $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments commencing September 17, 2021.